Kunle Odunsi

Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer

Julie R. Brahmer, Scott S. Tykodi, Laura Q.M. Chow et al. · New England Journal of Medicine · 2012 · 8K citations · Full text

Life Sciences, Immunology, Oncology +17

Intraepithelial CD8 ⁺ tumor-infiltrating lymphocytes and a high CD8 ⁺ /regulatory T cell ratio are associated with favorable prognosis in ovarian cancer

Eiichi Sato, Sara H. Olson, Jiyoung Ahn et al. · Proceedings of the National Academy of Sciences · 2005 · 2.4K citations · Full text

Life Sciences, Immunology, Oncology +17

Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk

Ganna Chornokur, Hui‐Yi Lin, Jonathan P. Tyrer et al. · PLoS ONE · 2015 · 906 citations · Full text

Medicine, Genetics, Oncology +17

Gene expression markers of Tumor Infiltrating Leukocytes

Patrick Danaher, Sarah Warren, Lucas Dennis et al. · Journal for ImmunoTherapy of Cancer · 2017 · 850 citations · Full text

Medicine, Cancer Biology, Oncology +17

Tumor-infiltrating NY-ESO-1–specific CD8 ⁺ T cells are negatively regulated by LAG-3 and PD-1 in human ovarian cancer

Junko Matsuzaki, Sacha Gnjatic, Paulette Mhawech‐Fauceglia et al. · Proceedings of the National Academy of Sciences · 2010 · 845 citations · Full text

Life Sciences, Immunology, Oncology +17